Literature DB >> 24298917

Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Jennifer K Logan1, Soroush Rais-Bahrami, Baris Turkbey, Andrew Gomella, Hayet Amalou, Peter L Choyke, Bradford J Wood, Peter A Pinto.   

Abstract

Prostate MRI is currently the best diagnostic imaging method for detecting PCa. Magnetic resonance imaging (MRI)/ultrasonography (US) fusion allows the sensitivity and specificity of MRI to be combined with the real-time capabilities of transrectal ultrasonography (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include direct 'in bore' MRI biopsies, cognitive fusion, and MRI/US fusion via software-based image coregistration platforms.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  MRI/US fusion; MRI/US fusion platforms; prostate MRI; targeted biopsy

Mesh：

Year:  2014        PMID： 24298917      PMCID： PMC4568118          DOI： 10.1111/bju.12593

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


  48 in total

1.  Real time MRI-ultrasound image guided stereotactic prostate biopsy.

Authors:  Irving Kaplan; Nicklas E Oldenburg; Paul Meskell; Michael Blake; Paul Church; Edward J Holupka
Journal:  Magn Reson Imaging       Date:  2002-04       Impact factor: 2.546

2.  Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study.

Authors:  Joseph C Presti; Gerard J O'Dowd; M Craig Miller; Rubina Mattu; Robert W Veltri
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

3.  Assessment of screening for prostate cancer using the digital rectal examination.

Authors:  G W Chodak; P Keller; H W Schoenberg
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

4.  Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.

Authors:  John C Rabets; J Stephen Jones; Amit Patel; Craig D Zippe
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

5.  Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.

Authors:  Kristen L Zakian; Steven Eberhardt; Hedvig Hricak; Amita Shukla-Dave; Shanon Kleinman; Manickam Muruganandham; Kanishka Sircar; Michael W Kattan; Victor E Reuter; Peter T Scardino; Jason A Koutcher
Journal:  Radiology       Date:  2003-08-14       Impact factor: 11.105

6.  Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.

Authors:  Tamar Sella; Lawrence H Schwartz; Peter W Swindle; Chinyere N Onyebuchi; Peter T Scardino; Howard I Scher; Hedvig Hricak
Journal:  Radiology       Date:  2004-04-02       Impact factor: 11.105

7.  Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.

Authors:  Soroush Rais-Bahrami; M Minhaj Siddiqui; Baris Turkbey; Lambros Stamatakis; Jennifer Logan; Anthony N Hoang; Annerleim Walton-Diaz; Srinivas Vourganti; Hong Truong; Jochen Kruecker; Maria J Merino; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2013-05-29       Impact factor: 7.450

8.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Hong Truong; Lambros Stamatakis; Srinivas Vourganti; Jeffrey Nix; Anthony N Hoang; Annerleim Walton-Diaz; Brian Shuch; Michael Weintraub; Jochen Kruecker; Hayet Amalou; Baris Turkbey; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

9.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate.

Authors:  K K Hodge; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

10.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450
View more
  34 in total

Review 1.  Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.

Authors:  Michael Kongnyuy; Arvin K George; Ardeshir R Rastinehad; Peter A Pinto
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

2.  Prostate cancer: MRI-TRUS fusion biopsy versus 12-core systematic biopsy.

Authors:  Gauthami Churukanti; Mohummad M Siddiqui
Journal:  Nat Rev Urol       Date:  2015-06-16       Impact factor: 14.432

3.  Open-source image registration for MRI-TRUS fusion-guided prostate interventions.

Authors:  Andriy Fedorov; Siavash Khallaghi; C Antonio Sánchez; Andras Lasso; Sidney Fels; Kemal Tuncali; Emily Neubauer Sugar; Tina Kapur; Chenxi Zhang; William Wells; Paul L Nguyen; Purang Abolmaesumi; Clare Tempany
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-07       Impact factor: 2.924

Review 4.  MR/US Fusion Technology: What Makes It Tick?

Authors:  Srinivas Vourganti; Norman Starkweather; Andrij Wojtowycz
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

Review 5.  Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.

Authors:  Steven Sidelsky; Shaan Setia; Srinivas Vourganti
Journal:  Curr Urol Rep       Date:  2017-10-18       Impact factor: 3.092

Review 6.  Developing a National Center of Excellence for Prostate Imaging.

Authors:  Annerleim Walton-Diaz; Manuel Madariaga-Venegas; Nicolas Aviles; Juan Carlos Roman; Ivan Gallegos; Mauricio Burotto
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

7.  Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.

Authors:  Nabeel A Shakir; Arvin K George; M Minhaj Siddiqui; Jason T Rothwax; Soroush Rais-Bahrami; Lambros Stamatakis; Daniel Su; Chinonyerem Okoro; Dima Raskolnikov; Annerleim Walton-Diaz; Richard Simon; Baris Turkbey; Peter L Choyke; Maria J Merino; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2014-08-09       Impact factor: 7.450

8.  Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research.

Authors:  Srinivas Vourganti; Jeffrey Donaldson; Linda Johnson; Baris Turkbey; Gennady Bratslavsky; Leszek Kotula
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-30

9.  Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer.

Authors:  Dima Raskolnikov; Arvin K George; Soroush Rais-Bahrami; Baris Turkbey; Nabeel A Shakir; Chinonyerem Okoro; Jason T Rothwax; Annerleim Walton-Diaz; M Minhaj Siddiqui; Daniel Su; Lambros Stamatakis; Maria J Merino; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  J Endourol       Date:  2014-10-14       Impact factor: 2.942

Review 10.  Multimodal imaging for improved diagnosis and treatment of cancers.

Authors:  Clare M C Tempany; Jagadeesan Jayender; Tina Kapur; Raphael Bueno; Alexandra Golby; Nathalie Agar; Ferenc A Jolesz
Journal:  Cancer       Date:  2014-09-09       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.